Résultats de recherche

Fondé il y a une cinquantaine d’années, le Laboratoire d'Analyse par Réactions Nucléaires (LARN) du Département de physique de l’Université de Namur abrite un accélérateur de particules tandem 2MV nommé ALTAÏS (Accélérateur Linéaire Tandetron pour l’Analyse et l’Implantation des Solides), en service depuis 1999. 

Depuis septembre 2023, Marc Hennequart, professeur en biochimie et biologie cellulaire à l’UNamur, mène des recherches novatrices sur le cancer du pancréas. Son équipe, basée à la Faculté de médecine et à l’Institut Narilis, étudie les étapes précoces de l’oncogenèse (processus de transformation d’une cellule normale en une cellule cancéreuse) pour mieux comprendre les changements métaboliques à l’origine de ce cancer particulièrement agressif.

Au programme 16h00 | Accueil des participants dans le hall de la Faculté de médecine16h30 | Séance anniversaire et inaugurale17h30 | Drink et visite (en groupe) des laboratoiresParticipation externe sur invitation. Une question ?  Contacter Jean-François Colomer : jean-francois.colomer@unamur.be 

À l’occasion de la journée internationale des femmes et des filles de science proclamée le 11 février par l’Assemblée générale des Nations Unies et dans le cadre de l’alliance européenne European Space University for Earth and Humanity (UNIVERSEH) axée sur la thématique de l’espace, découvrez le témoignage de quatre femmes scientifiques de l’UNamur qui travaillent sur des thématiques d’astronomie. 

Belle victoire pour Margaux Mignolet, chercheuse au sein de l'Unité de Recherche en Physiologie Moléculaire (URPhyM) de la Faculté de médecine, qui remporte le 1er prix de la finale belge interuniversitaire du concours Ma thèse en 180 secondes (MT180). Sa recherche ? Mieux comprendre les mécanismes des anticorps actifs dans les cas de COVID long. Le deuxième prix de ce concours national a, lui aussi, été remporté par une candidate namuroise. Il s’agit de Petra Manja, issue de l'Unité de Recherche en biologie des micro-organismes (URBM), Département de biologie de la Faculté des sciences et qui poursuit une thèse visant à comprendre les mécanismes de résistance de la bactérie E. coli. Toutes deux sont également chercheuses au sein de l'Institut NARILIS.

Charting the DNA methylome landscape in cancer, chronic disease and phenotype Abstract: Our team has developed some of the first pipelines for genome-scale DNA methylation analysis. Our work has revealed aberrant methylation and expression patterns in several cancer types and revealed new mechanism of epigenetic regulation in cancer cells. We are now applying cutting-edge whole genome scale DNA methylation analysis in tissues as well as well as in cell free DNA (epigenetic liquid biopsy) and epigenetic editing platforms to investigate clinically relevant biomedical questions in cancer (for example, methylation map of colorectal, prostate, lung cancer and pancreatic cancer patients). Our work in epigenetic editing has implication in revealing causal function and new epigenetic regulation. In this talk, I will present the key findings from some of our works over the years and also elaborate on some recent and future directions in understanding the role of DNA methylation events in cancer metastasis, early detection, and treatment monitoring in solid cancers and also in chronic diseases and phenotype. More information on the ILEE website

Abstract Radiotherapy is a cornerstone of cancer treatment and is currently administered to approximately half of all cancer patients. However, the cytotoxic effects of ionizing radiation on normal tissues represent a major limitation, as they restrict the dose that can be safely delivered to patients and, consequently, reduce the likelihood of effective tumor control. In this context, delivering radiation at ultra-high dose rates (UHDR, > 40 Gy/s) is gaining increasing attention due to its potential to spare healthy tissues surrounding the tumor and to prevent radiation-induced side effects, as compared to conventional dose rates (CONV, on the order of Gy/min).The mechanism underlying this protective effect—termed the FLASH effect—remains elusive, driving intensive research to elucidate the biological processes triggered by this type of irradiation.In vitro models offer a valuable tool to support this research, allowing for the efficient screening of various beam parameters and biological responses in a time- and cost-effective manner. In this study, multicellular tumor spheroids and normal cells were exposed to proton irradiation at UHDR to evaluate its effectiveness in controlling tumor growth and its cytotoxic impact on healthy tissues, respectively.We report that UHDR and CONV irradiation induced a comparable growth delay in 3D tumor spheroids, suggesting similar efficacy in tumor control. In normal cells, both dose rates induced similar levels of senescence; however, UHDR irradiation led to lower apoptosis induction at clinically relevant doses and early time points post-irradiation.Taken together, these findings further highlight the potential of UHDR irradiation to modulate the response of normal tissues while maintaining comparable tumor control.JuryProf. Thomas BALLIGAND (UNamur), PrésidentProf. Stéphane LUCAS (UNamur), SecrétaireProf. Carine MICHIELS (UNamur)Dr Sébastien PENNINCKX (Hôpital Universitaire de Bruxelles)Prof. Cristian FERNANDEZ (Université de Bern)Dr Rudi LABARBE (IBA)

La deadline d'inscription et de soumission pour les abstracts : 20 août 2025.  Plus d'infos sur le site internet de l'Institut NARILIS

Abstract Primarily described as an alarmone, secondary messenger (p)ppGpp, when accumulated, binds to many targets involved in DNA replication, translation, and transcription. In the asymmetrically-dividing a-proteobacterium Caulobacter crescentus, (p)ppGpp has been shown to strongly impact cell cycle progression and differentiation, promoting the non-replicating G1/swarmer phase. Mutations in the major subunits of transcriptional complex, b or b’ subunits, were able to display the (p)ppGpp-related phenotypes even in the absence of the alarmone. We identified that the transcriptional holo-enzyme, RNA polymerase (RNAP) is a primary target of (p)ppGpp in C. crescentus. Furthermore, mutations that inactivate (p)ppGpp binding to RNAP annihilated the (p)ppGpp-related phenotypes and phenocopied a (p)ppGpp0 strain. Our RNAseq analysis further elucidated the changes in the transcriptional landscape of C. crescentus cells displaying different (p)ppGpp levels and expressing RNAP mutants. Since the DNA replication initiation protein DnaA is required to exit the G1 phase, we observed that it was significantly less abundant in cells accumulating (p)ppGpp. We further explored its proteolysis under the influence of (p)ppGpp. Our work suggests that (p)ppGpp regulates cell cycle and differentiation in C. crescentus by reprogramming transcription and triggering proteolytic degradation of key cell cycle regulators by yet unknown mechanisms. In Part II, we identified two σ factors belonging to the ECF family that might be involved in this (p)ppGpp-accompanied phenotypes. In Part III, we propose an overlapping role of the ω subunit, RpoZ, and the heat shock subunit, RpoH, in carbon metabolism.JuryProf. Gipsi LIMA MENDEZ (UNamur), PresidentProf Régis HALLEZ (UNamur), SecretaryDr Emanuele BIONDI (CNRS-Université Paris-Saclay)Prof. Justine COLLIER (University of Lausanne)Dr Marie DELABY (Université de Montréal)

Abstract Estrogens originating from human and animal excretion, as well as from anthropogenic sources such as cosmetics, plastics, pesticides, detergents, and pharmaceuticals, are among the most concerning endocrine-disrupting compounds in aquatic environments due to their potent estrogenic activity. While their effects on fish reproduction are well documented, their impact on development, particularly metamorphosis, remains poorly studied. This hormonal transition, mainly controlled by the thyroid axis, is essential for the shift from the larval to the juvenile stage in teleosts.The effects of two contraceptive estrogens on zebrafish (Danio rerio) metamorphosis were evaluated: 17α-ethinylestradiol (EE2), a synthetic reference estrogen, and estetrol (E4), a natural estrogen recently introduced in a new combined oral contraceptive formulation. Continuous exposure from fertilization to the end of metamorphosis allowed the assessment of morphological changes, disruptions of the thyroid axis, and modifications of additional molecular pathways potentially involved in metamorphic regulation.EE2 induced significant delays and disturbances in metamorphosis, affecting both internal and external morphological traits, confirming its role as an endocrine disruptor of concern. In contrast, E4 did not cause any detectable morphological alterations even at concentrations far exceeding those expected in the environment, indicating a limited ecotoxicological risk. Molecular analyses showed that EE2 strongly affected thyroid signaling and energy metabolism during metamorphosis, whereas E4 induced only minor transcriptional and proteomic changes.This study provides the first evidence that EE2 can disrupt zebrafish metamorphosis and highlights the importance of including this developmental stage in ecotoxicological assessments. The results also suggest a larger environmental safety margin for E4, although further research is needed to clarify the mechanisms linking estrogen exposure to metamorphic regulation.JuryProf. Frederik DE LAENDER (UNamur), PrésidentProf. Patrick KESTEMONT (UNamur), SecrétaireDr Sébastien BAEKELANDT (UNamur)Dr Valérie CORNET (UNamur)Prof. Jean-Baptiste FINI (Muséum National d’Histoire Naturelle de Paris)Dr Marc MULLER (ULiège)Prof. Veerle DARRAS (KULeuven)